Cargando…
Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208892/ https://www.ncbi.nlm.nih.gov/pubmed/35747590 http://dx.doi.org/10.1097/HS9.0000000000000742 |
_version_ | 1784729811669745664 |
---|---|
author | Stemler, Jannik Cornely, Oliver A. |
author_facet | Stemler, Jannik Cornely, Oliver A. |
author_sort | Stemler, Jannik |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9208892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-92088922022-06-22 Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies Stemler, Jannik Cornely, Oliver A. Hemasphere Editorial Lippincott Williams & Wilkins 2022-06-17 /pmc/articles/PMC9208892/ /pubmed/35747590 http://dx.doi.org/10.1097/HS9.0000000000000742 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Editorial Stemler, Jannik Cornely, Oliver A. Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title | Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title_full | Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title_fullStr | Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title_full_unstemmed | Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title_short | Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies |
title_sort | antifungal prophylaxis in acute myeloid leukemia: new drugs, new challenges?: summary of the eha guideline on antifungal prophylaxis in adult patients with acute myeloid leukemia treated with novel-targeted therapies |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208892/ https://www.ncbi.nlm.nih.gov/pubmed/35747590 http://dx.doi.org/10.1097/HS9.0000000000000742 |
work_keys_str_mv | AT stemlerjannik antifungalprophylaxisinacutemyeloidleukemianewdrugsnewchallengessummaryoftheehaguidelineonantifungalprophylaxisinadultpatientswithacutemyeloidleukemiatreatedwithnoveltargetedtherapies AT cornelyolivera antifungalprophylaxisinacutemyeloidleukemianewdrugsnewchallengessummaryoftheehaguidelineonantifungalprophylaxisinadultpatientswithacutemyeloidleukemiatreatedwithnoveltargetedtherapies |